Stereotactic Radiosurgery for Multiple Brain Metastases From Renal-Cell Carcinoma.

ABSTRACT:

Background

Brain metastases (BM) pose a significant problem in patients with metastatic renal-cell carcinoma (mRCC). Local and systemic therapies including stereotactic radiosurgery (SRS) are rapidly evolving, necessitating reassessments of outcomes for modern patient management.

Patients and methods

The mRCC patients with BM treated with SRS were reviewed. Patient demographics, clinical history, and SRS treatment parameters were identified.

Results

Among 268 patients with mRCC treated between 2006 and 2015, 38 patients were identified with BM. A total of 243 BM were treated with SRS with 1 to 26 BMs treated per SRS session (median, 2 BMs). The median (range) BM size was 0.6 (0.2-3.1) cm and median (range) SRS treatment dose was 18 (12-24) Gy. Treated BM local control

SUBMITTER: Wardak Z 

PROVIDER: S-EPMC6563340 | biostudies-literature | 2019 Apr

REPOSITORIES: biostudies-literature